21. Comparative effect of valsartan-amlodipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients. (August 2022) Authors: Liontos, A.; Biros, D.; Papathanasiou, A.; Papagiannopoulos, C.; Klouras, E.; Tsourlos, S.; Athanasiou, L.; Filippas-Ntekouan, S.; Zarachi, A.; Kolios, N.-G.; Pappa, C.; Samanidou, V.; Christaki, E.; Liberopoulos, E.; Elisaf, M.; Milionis, H.; Liamis, G. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Comparative effect of valsartan-amlodipine treatment versus telmisartan-amlodipine treatment in HOMA-IR, HOMA-B, HOMA-S and QUICKI indexes in prediabetic hypertensive patients. (August 2022) Authors: Liontos, A.; Filippas-Ntekouan, S.; Biros, D.; Kolios, N.-G.; Papagiannopoulos, C.; Veliani, C.; Papathanasiou, A.; Samanidou, V.; Tsourlos, S.; Athanasiou, L.; Pappa, C.; Pargana, E.; Nasiou, M.; Zarachi, A.; Vagias, I.; Tsiakas, I.; Christaki, E.; Elisaf, M.; Liberopoulos, E.; Milionis, H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Comparison of switch to the highest dose of rosuvastatin vs. add‐on nicotinic acid vs. add‐on fenofibrate for mixed dyslipidaemia. Issue 5 (20th March 2013) Authors: Kei, A.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. Journal: International journal of clinical practice Issue: Volume 67:Issue 5(2013) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Diagnostic lipid changes in patients with visceral leishmaniasis. (August 2018) Authors: Kei, A.; Tsimihodimos, V.; Apostolou, F.; Elisaf, M. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis. (September 2016) Authors: Barkas, F.; Elisaf, M.; Tsimihodimos, V.; Milionis, H. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Distance To Targets Of Low-Density Lipoprotein Cholesterol And Eligibility For Treatment With Pcsk9 Inhibitors In Patients At High Cardiovascular Risk. (August 2019) Authors: Barkas, F.; Elisaf, M.; Dimitriou, T.; Liamis, G.; Rizos, E.; Liberopoulos, E. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Effect Of Anti-Hyperglycemic Agents On Serum Pcsk9 Levels. (August 2019) Authors: Filippas-Ntekouan, S.; Pappa, E.; Tzavella, E.; Tellis, K.; Tselepis, A.; Elisaf, M.; Bairaktari, E.; Tsimihodimos, V. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Effect Of Anti-Hyperglycemic Agents On Serum Pcsk9 Levels. (August 2019) Authors: Filippas-Ntekouan, S.; Pappa, E.; Tzavella, E.; Tellis, C.; Tselepis, A.D.; Elisaf, M.; Bairaktari, E.; Tsimihodimos, V. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Effect Of Dapagliflozin And Sitagliptin On Serum Lipids And Lipoprotein Subfractions. (August 2019) Authors: Filippas-Ntekouan, S.; Tellis, K.; Tselepis, A.; Bairaktari, E.; Dimitriou, T.; Christopoulou, E.; Elisaf, M.; Tsimihodimos, V. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Effect of nebivolol or nebivolol/hydrochlorothiazide plus atorvastatin on glycemic profile in patients with hypertension and dyslipidemia. Issue 1 (July 2015) Authors: Kei, A.; Liberopoulos, E.; Elisaf, M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗